MedPath

SMS Technology for the Promotion of Diabetes Education and Self-Management in Egypt

Not Applicable
Completed
Conditions
Diabetes Mellitus
Interventions
Other: SMS messages
Other: Instruction booklet
Registration Number
NCT02868320
Lead Sponsor
Hannover Medical School
Brief Summary

This study was conducted at the teaching hospital of Misr University for Science \& Technology. It aimed to examine the use of SMS technology in educating and monitoring diabetic patients in Egypt, and assess the impact of educational text messages on their glycemic control and self-management behaviors. Participants were randomized into an intervention and a control group. Intervention patients received an instruction booklet as well as daily educational and weekly reminder messages to better control their diabetes. Control patients received the same instruction booklet but no SMS messages. Both group patients took an HbA1c test at the beginning and end of the study period and were asked to measure their blood glucose once a week and record their readings into a monitoring table over 12 weeks. The primary outcome was the change in HbA1c levels, which was expected to be greater among intervention patients at the end of the study. Secondary outcomes included blood glucose levels, treatment and medication adherence, diabetes self-efficacy, rate of hospital/ER visits, frequency of blood glucose measurement, among others.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • has diabetes
  • owns a mobile phone
  • can read SMS messages or lives with someone that can read for them.
Exclusion Criteria
  • cannot read or not SMS familiar and lives alone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupInstruction bookletThis group received a diabetes instruction booklet in addition to daily educational SMS messages and weekly reminders
Intervention groupSMS messagesThis group received a diabetes instruction booklet in addition to daily educational SMS messages and weekly reminders
Control groupInstruction bookletThis group only received a diabetes instruction booklet
Primary Outcome Measures
NameTimeMethod
change in HbA1cbaseline and 12 weeks

measured by the difference between endpoint and baseline values and by the number of patients who experienced a reduction of at least 1% from baseline to endpoint

Secondary Outcome Measures
NameTimeMethod
blood glucose levels12 weeks
body weight12 weeks
Rate of hospital/ER admissions12 weeks
Treatment adherence12 weeks

measured by the diabetes self-care inventory (SCI)

Diabetes self-efficacy12 weeks

measured by the diabetes empowerment scale short form (DES-SF)

Frequency of blood glucose measurement12 weeks
Medication adherence12 weeks

measured by the Morisky medication adherence scale (MMAS-4)

Trial Locations

Locations (1)

Misr University for Science & Technology (MUST) hospital

🇪🇬

Giza, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath